EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update

Seza Ozen, Erdal Sağ, Teresa Oton, Ahmet Gül, Cristiana Sieiro Santos, Deniz Bayraktar, Fabian Nikolai Proft, Helen J Lachmann, Jasmin Kuemmerle Deschner, Marco Gattorno, Nuray Aktay Ayaz, Ömer Karadağ und 10 weitere

Annals of the Rheumatic Diseases · 2025-06 · 84 (6) · 899-909

DOI: 10.1016/j.ard.2025.01.028 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Annals of the Rheumatic Diseases, 2025-06. Verfasst von Seza Ozen und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Rheumatology, Hacettepe University, Ankara, Turkey. Electronic address: sezaozen@gmail.com. Hauptthemen laut MEDLINE: Familial Mediterranean Fever. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EULAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease despite being a rare disease for many rheumatologists. These evidence-based recommendations update the ones issued in 2016 to account for the recent developments in the field and aim to guide rheumatologists and other health professionals in the treatment and follow-up of patients with FMF. METHODS: A multidisciplinary panel was assembled, including rheumatologists, internists, paediatricians, a nephrologist, an occupational therapist, a physiotherapist, 2 methodologists, and 2 patient representatives, all from the Eastern Mediterranean area and Europe. Several systematic reviews were performed on the pharmacological treatment of FMF and its complications. The previous recommendations were revised considering the updated evidence, and the new levels of evidence were incorporated. The agreement with the recommendations was obtained through a Delphi survey. RESULTS: The final set comprises 4 overarching principles and 12 recommendations, each presented with its degree of agreement (0-10), level of evidence, and rationale. The degree of agreement was greater than 9/10 in all instances, and the level of evidence improved in most updated statements. Improving adherence is emphasised as an important aspect in several statements. These new recommendations include a priority set, quality indicators, and other suggested implementation strategies. CONCLUSIONS: This article presents a set of widely accepted recommendations for treating and monitoring FMF, supported by the best available evidence and expert opinion. These recommendations are valuable for guiding physicians in caring for patients with FMF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Familial Mediterranean FeverHumansColchicineEvidence-Based MedicineDelphi Technique

Substanzen

Colchicine

Autor:innen und Institutionen

  • Department of Paediatric Rheumatology, Hacettepe University, Ankara, Turkey. Electronic address: sezaozen@gmail.com.
  • Department of Paediatric Rheumatology, Hacettepe University, Ankara, Turkey.
  • Instituto de Salud Musculoesquelética, Madrid, Spain.
  • Department of Internal Medicine, Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Rheumatology Department, Complejo Asistencial Universitario de León, Spain.
  • Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Izmir Katip Celebi University, Izmir, Turkey; Arthritis Research Canada, Vancouver, BC, Canada.

Förderung

  • EULAR

Zitieren

APA

Ozen, S., Sağ, E., Oton, T., Gül, A., Sieiro Santos, C., Bayraktar, D., Proft, F. N., Lachmann, H. J., Kuemmerle Deschner, J., Gattorno, M., Ayaz, N. A., Karadağ, Ö., Yüce, S., Kivity, S., Georgin-Lavialle, S., Sarkisian, T., Kallinich, T., Hentgen, V., Prior, Y., …, & Carmona, L. (2025). EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update. Annals of the Rheumatic Diseases, 84(6), 899-909. https://doi.org/10.1016/j.ard.2025.01.028

Vancouver

Ozen S, Sağ E, Oton T, Gül A, Sieiro Santos C, Bayraktar D, et al. EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update. Annals of the Rheumatic Diseases. 2025;84(6):899-909. doi:10.1016/j.ard.2025.01.028

BibTeX
@article{Ozen2025,
  author = {Ozen, Seza and Sağ, Erdal and Oton, Teresa and Gül, Ahmet and Sieiro Santos, Cristiana and Bayraktar, Deniz and Proft, Fabian Nikolai and Lachmann, Helen J and Kuemmerle Deschner, Jasmin and Gattorno, Marco and Ayaz, Nuray Aktay and Karadağ, Ömer and Yüce, Sezin and Kivity, Shaye and Georgin-Lavialle, Sophie and Sarkisian, Tamara and Kallinich, Tilmann and Hentgen, Véronique and Prior, Yeliz and Uziel, Yosef and Yardeni, Ziv and Carmona, Loreto},
  title = {EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update},
  journal = {Annals of the Rheumatic Diseases},
  year = {2025},
  volume = {84},
  number = {6},
  pages = {899--909},
  doi = {10.1016/j.ard.2025.01.028}
}
Kostenlos starten →